Circulating sEVs of melanoma patients have a characteristic protein signature indicating metastasis, which is characterized by increased levels of tyrosinase-related protein 2 (TYRP2), very late antigen 4 (VLA4), HSP70 and the oncoprotein MET [135]. This evidence concerns the gene DCT and melanoma.